What’s New in Urology
The latest, up to date treatment information
Urinary and Fecal Incontinence:
Interstim therapy is a proven neuromodulation therapy that targets the communication problem between the brain and the nerves that control the bladder. Not only does Interstim treat urinary retention, but as of 2011, Interstim therapy has been FDA approved to treat fecal incontinence. Dr. Fernandez-Salvador is now treating patients for both urinary and fecal incontinence and is happy to answer any of your questions about the latest treatment advantages.
Advanced Prostate Cancer Treatment:
One in eight men will be diagnosed with prostate cancer in their lifetime. Florida Urology Physicians is the first urology practice in southwest Florida to offer suitable prostate cancer patients Provenge–a new, innovative immunotherapy. PROVENGE is the only FDA-approved autologouscellularimmunotherapy indicated for the treatment of asymptomatic or minimally symptomaticmetastaticcastrate resistant (hormone refractory) prostate cancer. Provenge is not a chemotherapy drug and is different from hormone therapy. In a clinical study, PROVENGE extended median survival beyond 2 years.
Botox to treat Overactive Bladder and Urinary Incontinence:
The FDA has approved Botox to treat overactive bladder and urinary incontinence that stems from neurological causes. The drug increases the capacity of the bladder to hold more urine and relaxes the muscle to stop unexpected urine leakage. This treatment can last up to nine months.
Injectable Implant to treat Stress Urinary Incontinence in Women:
Over 13 million adults have stress urinary incontinence in the United States, 85% of these adults being women. The newest treatment for stress urinary incontinence is the Coaptitie injectable implant. The Coaptite Injectable Implant is a material used to bulk out the tissues surrounding the urethra to provide additional support during physical activity. This procedure is done in office or at our surgery center and takes approximately 15-20 minutes.
Latest Treatment for Testosterone Deficiency:
We are now providing patients afflicted with Testosterone Deficiency Syndrome an in-office, 10 minute, insertion procedure to normalize Low Testosterone levels. TESTOPEL® is the only FDA-approved implantable testosterone pellet used to combat the symptoms and effects of Low Testosterone. The testosterone pellets work by releasinga constant supply of testosterone into the body, which can last for up to six months.
Clinical Research Announcement:
Florida Urology Physicians is pleased to announce the addition of a clinical research center at their Fort Myers office location. Dr. Barry Blitz, Principal Investigator, is currently working on four research studies. Potential participants need not be established patients within our practice. Please call for 239-689-8800 for information about our clinical research studies.
For more information on the latest treatments and advancements in urology, the physicians at Florida Urology Physicians can be reached at 239-689-8800.